Does MACITENTAN Cause Central venous catheterisation? 78 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 78 reports of Central venous catheterisation have been filed in association with MACITENTAN (OPSYNVI). This represents 0.2% of all adverse event reports for MACITENTAN.
78
Reports of Central venous catheterisation with MACITENTAN
0.2%
of all MACITENTAN reports
7
Deaths
72
Hospitalizations
How Dangerous Is Central venous catheterisation From MACITENTAN?
Of the 78 reports, 7 (9.0%) resulted in death, 72 (92.3%) required hospitalization.
Is Central venous catheterisation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MACITENTAN. However, 78 reports have been filed with the FAERS database.
What Other Side Effects Does MACITENTAN Cause?
Dyspnoea (8,315)
Death (5,864)
Headache (4,856)
Diarrhoea (3,669)
Pneumonia (3,531)
Nausea (3,463)
Hospitalisation (3,414)
Fatigue (3,172)
Fluid retention (2,861)
Dizziness (2,704)
What Other Drugs Cause Central venous catheterisation?
EPOPROSTENOL (361)
AMBRISENTAN (263)
TREPROSTINIL (208)
ECULIZUMAB (105)
VENETOCLAX (89)
PEMBROLIZUMAB (70)
AZTREONAM LYSINE (63)
ADALIMUMAB (59)
NATALIZUMAB (57)
GLYCINE\MANNITOL\SODIUM (56)
Which MACITENTAN Alternatives Have Lower Central venous catheterisation Risk?
MACITENTAN vs MACITENTAN\TADALAFIL
MACITENTAN vs MAGNESIUM
MACITENTAN vs MAGNESIUM ASPARTATE
MACITENTAN vs MAGNESIUM ASPARTATE\POTASSIUM ASPARTATE
MACITENTAN vs MAGNESIUM HYDROXIDE